机构:[1]Department of Cardiology, the Affiliated Cardiovascular Hospital of Kunming Medical University (Fuwai Yunnan Cardiovascular Hospital), Kunming, China.[2]Department of Orthopedic and Trauma Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, China.
This work was supported by scientific research funding from the
2018 Science and Technology Plan Project of the Yunnan
Provincial Science and Technology Department. Grant
Program [2018FE001 (–285)].
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区免疫学
最新[2023]版:
大类|2 区医学
小类|2 区免疫学
第一作者:
第一作者机构:[1]Department of Cardiology, the Affiliated Cardiovascular Hospital of Kunming Medical University (Fuwai Yunnan Cardiovascular Hospital), Kunming, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhao Shijian,Wu Yinteng,Wei Yantao,et al.Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis[J].Frontiers in immunology.2022,13:876616.doi:10.3389/fimmu.2022.876616.
APA:
Zhao Shijian,Wu Yinteng,Wei Yantao,Xu Xiaoyu&Zheng Jialin.(2022).Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis.Frontiers in immunology,13,
MLA:
Zhao Shijian,et al."Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis".Frontiers in immunology 13.(2022):876616